Andorra vs South-Eastern Asia: Proportion of the target population who received
Andorra
97.0%
in 2024
South-Eastern Asia
81.0%
in 2024
Andorra rank
21st
South-Eastern Asia rank
16th
Proportion of the target population who received over time
- Andorra
- South-Eastern Asia
How they compare
Andorra currently reports 97.0% against 81.0% in South-Eastern Asia, a difference of 16.0%.
That makes Andorra's figure about 1.2 times South-Eastern Asia's.
Across all 18 years both countries report, Andorra has been ahead every year.
Andorra ranks 21st and South-Eastern Asia ranks 16th of 193 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.7% | 53.7% | 29.0% | Andorra |
| 2010s | 90.2% | 67.7% | 22.5% | Andorra |
| 2020s | 95.8% | 71.8% | 24.0% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Andorra or South-Eastern Asia?
- Andorra, at 97.0% against 81.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received between Andorra and South-Eastern Asia?
- 16.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and South-Eastern Asia?
- 18 years are reported by both, from 2007 to 2024.
- How do Andorra and South-Eastern Asia rank globally for proportion of the target population who received?
- Andorra ranks 21st and South-Eastern Asia ranks 16th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.